Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers CSF and blood were collected simultaneously from patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results